Thermo Fisher buys coronavirus test maker Qiagen in biggest healthcare of the deal of the year. Bregal Sagemount raises third fund. In more PE news, AEI, GTCR and FP make deals.
As India’s first billion-dollar share sale in more than two years and the only credit card firm in the nation to go public, SBI Cards and Payment Services Ltd.’s float may exceed the $1.4 billion target. The question is by how much in the face of the coronavirus outbreak.
The Federal Reserve has voted unanimously to cut the interest rate 50 basis points to 1.10% effective March 4, in the first emergency rate cut since 2008.
Looming state budget cuts combined with the COVID-19 threat could have a negative impact on NYC's economy.
The Federal Open Market Committee cut the fed funds rate target 50 basis points to a range between 1% and 1.25%, it announced Tuesday.
When a new coronavirus emerged out of China in January, Qiagen got to work on a test to detect the virus in bodily fluids. The test is now being evaluated at four hospitals in China and one in France. The diagnostic gives results in about one hour.
The disease could lead to less lending business and more loan defaults; Sergio Ermotti will join the insurance company as chairman in 2021.
Something as simple as the sale of cheese can show how fear instantly affects the economy, disrupting trade and the transaction fees that processors rely on.
Policymakers could recommend banks establish backup facilities and the Federal Reserve could stand ready with emergency loans to limit economic shock waves.
Even as the virus forces companies and workers to accept the reality of remote work, many are complaining that that in reality, firms are simply not equipped or prepared to let employees work remotely.